Citations

Showing 10 of 108094 citations.

Commentary: Far Lateral Approach With Intraoperative Indocyanine Green Angiography for Craniocervical Arteriovenous Fistula Obliteration: 2-Dimensional Operative Video
Singh, Rohin , Turcotte, Evelyn L. , Melita, Nicolae Teodor, Bocanegra-Becerra, Jhon E, Singh, Rohin , Bendok, Bernard R.

Mayo Clinic

Operative Neurosurgery | August 16, 2022 | Volume: 23 | Issue: 3 | Pages: e203-e204

10.1227/ons.0000000000000335 | PMID 35972117 Get It

Commentary: Transorbital Endoscopic Eyelid Approach for Resection of Spheno-Orbital Meningioma: 2-Dimensional Operative Video
Stonnington, Henry O. , Turcotte, Evelyn L. , Nome, Marie A. Di , Lettieri, Salvatore C. , Mrugała, Maciej M. , Porter, Alyx B. , Bendok, Bernard R. , Di Nome, Marie A, Bendok, Bernard R

Mayo Clinic

Operative Neurosurgery | August 16, 2022 | Volume: 23 | Issue: 3 | Pages: e195-e196

10.1227/ons.0000000000000342 | PMID 35972113 Get It

Commentary: Validation of Machine Learning-Based Automated Surgical Instrument Annotation Using Publicly Available Intraoperative Video
Bydon, Mohamad , Durrani, Sulaman , Mualem, William

Mayo Clinic

Operative Neurosurgery | August 16, 2022 | Volume: 23 | Issue: 3 | Pages: e158-e159

10.1227/ons.0000000000000285 | PMID 35972093 Get It

Precuneal Interhemispheric, Transtentorial Approach to a Dorsal Pontine Cavernous Malformation: 2-Dimensional Operative Video
Alexander, A. Yohan , Agosti, Edoardo , Leonel, Luciano, Kerezoudis, Panagiotis , Peris‐Celda, Maria , Agosti, Edoardo , Alexander, A Yohan , Lanzino, Giuseppe

Mayo Clinic

Operative Neurosurgery | August 16, 2022 | Volume: 23 | Issue: 3 | Pages: e173-e173

10.1227/ons.0000000000000301 | PMID 35972100 Get It

Retrosigmoid Approach Using Suboccipital Osteoplastic Craniotomy for Resection of Vestibular Schwannoma: 2-Dimensional Operative Video
Spear, Joshua A. , Bauman, Megan M. J. , Graffeo, Christopher S. , Nassiri, Ashley M. , Carlson, Matthew L. , Gompel, Jamie J. Van , Van Gompel, Jamie J , Bauman, Megan

Mayo Clinic

Operative Neurosurgery | August 16, 2022 | Volume: 23 | Issue: 3 | Pages: e171-e172

10.1227/ons.0000000000000300 | PMID 35972099 Get It

Editorial Comment
Koo, Kevin , Findlay, Bridget L.

Mayo Clinic

Journal of Urology | August 16, 2022 | Volume: 208 | Issue: 5 | Pages: 1073-1074

10.1097/ju.0000000000002836.01 | PMID 35971792 Get It

Clinical role of ambulatory reflux monitoring in PPI non‐responders: recommendation statements
Yadlapati, Rena , Gawron, Andrew J. , Gyawali, C. Prakash , Chen, Joan W. , Clarke, John O. , Jain, Anand , Lynch, Kristle L. , Khan, Abraham, Katz, Philip O. , Katzka, David A. , Richter, Joel E. , Schnoll‐Sussman, Felice , Vaezi, Michael F. , Vela, Marcelo F. , Pandolfino, John E. , Chen, Joan , Katzka, D A , Richter, Joel , Vela, Marcelo, Clarke, J , Gyawali, C P , Fass, Ronnie , Khan, Abraham, Spechler, Stuart Jon

Mayo Clinic

Alimentary Pharmacology & Therapeutics | August 16, 2022 | Volume: 56 | Issue: 8 | Pages: 1274-1283

10.1111/apt.17180 | PMID 35971888 Get It

Summary Background Optimal ambulatory reflux monitoring methodology in symptomatic reflux patients continues to be debated. Aims To utilise published literature and expert opinion to develop recommendation statements addressing use of ambulatory reflux monitoring in clinical practice Methods The RAND Appropriateness Method (RAM) was utilised among 17 experts with discussion, revision and two rounds of ranking of recommendation statements. Ambulatory reflux monitoring protocol, methodology and thresholds ranked as appropriate by ≥80% of panellists met the criteria for appropriateness. Results Prolonged (96‐h recommended) wireless pH monitoring off proton pump inhibitor (PPI) was identified as the appropriate diagnostic tool to assess the need for acid suppression in patients with unproven gastro‐oesophageal reflux disease (GERD) and persisting typical reflux symptoms despite once‐daily PPI. Acid exposure time (AET) <4.0% on all days of monitoring with negative reflux‐symptom association excludes GERD and does not support ongoing PPI treatment. Conversely, AET >6.0% across ≥2 days is conclusive evidence for GERD and supports treatment for GERD, while AET >10% across ≥2 days identifies severe acid burden that supports escalation of anti‐reflux treatment. In previously proven GERD, impedance‐pH monitoring on PPI is helpful in defining refractory GERD and mechanisms of continued symptoms; the presence of <40 reflux events, AET <2.0% and a negative reflux‐symptom association does not support escalation of anti‐reflux treatment. In contrast, AET > 4.0% and positive reflux‐symptom association support escalation of anti‐reflux treatment, including use of invasive therapeutics. Conclusions Statements meeting appropriateness for average clinical care have been identified when utilising reflux monitoring in patients with typical reflux symptoms and PPI non‐response.
Double trouble: rheumatic systemic tricuspid valve disease in congenitally corrected transposition of the great arteries
Ahmed, Rizwan , Ghalib, Hussam

Mayo Clinic

European Heart Journal - Case Reports | August 16, 2022 | Volume: 6 | Issue: 8 | Pages: No page available

10.1093/ehjcr/ytac339 | PMID 36043212 Get It

Recognizing and Defining Occasional Constipation: Expert Consensus Recommendations
Rao, Satish S.C. , Lacy, Brian E. , Emmanuel, Anton , Müller‐Lissner, S., Pohl, Daniel , Whorwell, Peter J. , Rao, Satish , Whorwell, Peter J , Quigley, Eamonn M.M.

Mayo Clinic

American Journal of Gastroenterology | August 16, 2022 | Volume: 117 | Issue: 11 | Pages: 1753-1758

10.14309/ajg.0000000000001945 | PMID 35971230 Get It

Constipation is a common problem, affects 15% of the population, and is often self-diagnosed and self-managed. Over the past 3 decades, there have been significant advances in our understanding and management of chronic constipation, with the emerging recognition that occasional constipation (OC) is another subtype that falls outside current classifications. The purpose of this review was to describe the process of developing and proposing a new definition for OC based on expert consensus and taking into consideration the multifactorial nature of the problem such as alterations in bowel habit that include stool frequency and difficulty with stool passage, perception of the sufferer, duration of symptoms, and potential responsiveness to treatment. Leading gastroenterologists from 5 countries met virtually on multiple occasions through an online digital platform to discuss the problem of OC and recommended a practical, user-friendly definition: “OC can be defined as intermittent or occasional symptomatic alteration(s) in bowel habit. This includes a bothersome reduction in the frequency of bowel movements and/or difficulty with passage of stools but without alarming features. Bowel symptoms may last for a few days or a few weeks, and episodes may require modification of lifestyle, dietary habits and/or use of over-the-counter laxatives or bulking agents to restore a satisfactory bowel habit.” Prospective studies are required to validate this definition and determine OC prevalence in the community. This review highlights current knowledge gaps and could provide impetus for future research to facilitate an improved understanding of OC and development of evidence-based management guidelines.
What Muscle Signals Mediate the Beneficial Effects of Exercise on Cognition?
Benarroch, Eduardo E.

Mayo Clinic

Neurology | August 15, 2022 | Volume: 99 | Issue: 7 | Pages: 298-304

10.1212/wnl.0000000000201049 | PMID 35970575 Get It